Page 128 - 《中国药房》2023年2期
P. 128

·综述·


          青蒿素及其衍生物防治心血管疾病的研究进展
                                                                                  Δ

                           2 #
                 1*
          罗文宽 ,卢健棋 ,陈文鹏 ,庞 延 ,潘朝锌 ,温志浩(1.广西中医药大学研究生院,南宁 530001;2.广西中
                                                    2
                                            2
                                    3
                                                            2
          医药大学第一附属医院心内科/国家中医心血管病临床医学研究中心分中心,南宁 530022;3.云南中医药大学
          第二附属医院神经心血管科,昆明 650215)
          中图分类号  R531.3;R972      文献标志码  A      文章编号  1001-0408(2023)02-0246-05
          DOI  10.6039/j.issn.1001-0408.2023.02.23

          摘   要  青蒿素是从植物青蒿中分离出来的含过氧基团的倍半萜内酯,具有抗疟疾活性,是治疗疟疾的有效药物。随着人们对青
          蒿素研究的逐步深入,青蒿素及其衍生物在其他系统的药理作用也逐渐成为研究的热点。本文对青蒿素及其衍生物防治心血管
          疾病的研究进展进行了综述。青蒿素及其衍生物在心血管疾病的防治中显示出了抗动脉粥样硬化、降血脂、抑制血管重塑、降压、
          改善心室重构、抗心律失常、保护血管内皮、防治糖尿病心血管并发症及保护心肌细胞等药理作用,为高血压、心律失常、冠心病支
          架置入术后并发症、高脂血症等心内科常见疾病提供了新的治疗策略。但关于青蒿素及其衍生物的抗血小板聚集作用、抗血栓的
          研究较少,很多药理作用背后的分子机制尚未明确,且临床应用不多,仍然需要大量的基础研究和临床试验来解答这些问题。
          关键词  青蒿素;衍生物;心血管疾病;药理作用

          Research progress of artemisinin and its derivatives in prevention and treatment of cardiovascular diseases
          LUO Wenkuan ,LU Jianqi ,CHEN Wenpeng ,PANG Yan ,PAN Chaoxin ,WEN Zhihao(1.  Graduate  School,
                                                              2
                                                                            2
                                                                                         2
                                                  3
                                  2
                       1
          Guangxi  University  of  Chinese  Medicine,  Nanning  530001,  China;2.  Dept.  of  Cardiology,  the  First Affiliated
          Hospital  of  Guangxi  University  of  Chinese  Medicine/Branch  Center,  National  Clinical  Medical  Research  Center
          of  Traditional  Chinese  Medicine  for  Cardiovascular  Disease,  Nanning  530022,  China;3.  Dept.  of
          Neurocardiology,  the  Second Affiliated  Hospital  of Yunnan  University  of  Chinese  Medicine,  Kunming  650215,
          China)
          ABSTRACT    Artemisinin  is  a  sesquiterpene  lactone  containing  a  peroxide  group  isolated  from  the  plant Artemisia  annua.  It  has
          antimalarial  activity  and  is  effective  for  the  treatment  of  malaria.  With  the  deepening  of  research  on  artemisinin,  the
          pharmacological  effects  of  artemisinin  and  its  derivatives  in  other  systems  have  gradually  become  a  research  hotspot.  This  article
          reviews  the  research  progress  of  artemisinin  and  its  derivatives  in  the  prevention  and  treatment  of  cardiovascular  diseases.
          Artemisinin  and  its  derivatives  in  the  prevention  and  treatment  of  cardiovascular  disease  have  shown  anti-atherosclerosis,  lipid-
          lowering,  inhibition  of  vascular  remodeling,  reducing  vascular  pressure,  improving  ventricular  remodeling,  anti-arrhythmia,
          protection  of  vascular  endothelium,  prevention  and  treatment  of  diabetic  cardiovascular  complications  and  protection  of  myocardial
          cells  and  other  pharmacological  effects.  It  provides  a  new  treatment  strategy  for  common  cardiovascular  diseases  such  as
          hypertension,  arrhythmia,  coronary  heart  disease  complications  after  stent  implantation,  hyperlipidemia,  etc.  However,  there  are
          few  studies  on  the  antiplatelet  aggregation  and  antithrombotic  effects  of  artemisinin  and  its  derivatives,  the  molecular  mechanisms
          behind  many  pharmacological  effects  have  not  yet  been  clarified,  and  there  is  little  clinical  application. A  large  number  of  basic
          studies and clinical trials are still needed to answer these questions.
          KEYWORDS     artemisinin; derivatives; cardiovascular disease; pharmacological effect



              青蒿素是从植物青蒿中分离出来的含过氧基团的                           C15H22O5,可溶于乙醇、乙醚,几乎不溶于水。屠呦呦等
          倍半萜内酯,仅由碳、氢、氧 3 种元素组成,分子式为                          学者根据葛洪《肘后备急方》的记载从青蒿中获得抗疟
                                                              活性化学部位,并从中发现青蒿素,开启了防治疟疾的
              Δ  基金项目 国 家 自 然 科 学 基 金 地 区 基 金 资 助 项 目(No.
                                                                    [1]
          82160887);广西自然科学基金资助项目(No.2021GXNSFBA196018);       新时代 。为了适应抗疟的需要,青蒿素活性代谢物双
          广西自然科学基金面上项目(No.2021GXNSFAA220111)                  氢青蒿素(dihydroarteminsinin,DHA)、脂质衍生物蒿甲
             *第一作者 硕士研究生。研究方向:中医药防治心血管疾病。                     醚、极性衍生物青蒿琥酯被陆续开发出来,与青蒿素一
          E-mail:18026358859@163.com
                                                                                              [2]
                                                              起降低了全球疟疾的发生率和病死率 。随着人们对青
              # 通信作者 主任医师,教授,博士生导师。研究方向:中医药防治
          心血管疾病。E-mail:lujianqi666@163.com                    蒿素研究的逐步深入,青蒿素及其衍生物对其他系统的

          · 246 ·    China Pharmacy  2023 Vol. 34  No. 2                               中国药房  2023年第34卷第2期
   123   124   125   126   127   128   129   130   131   132   133